- Home
- TERN vs NXP Comparison
TERN vs NXP Comparison
Compare TERN & NXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TERN
- NXP
- Stock Information
- Founded
- TERN 2017
- NXP 1992
- Country
- TERN United States
- NXP United States
- Employees
- TERN N/A
- NXP N/A
- Industry
- TERN Biotechnology: Pharmaceutical Preparations
- NXP Trusts Except Educational Religious and Charitable
- Sector
- TERN Health Care
- NXP Finance
- Exchange
- TERN Nasdaq
- NXP Nasdaq
- Market Cap
- TERN 634.5M
- NXP 699.7M
- IPO Year
- TERN 2021
- NXP N/A
- Fundamental
- Price
- TERN $7.13
- NXP $14.34
- Analyst Decision
- TERN Buy
- NXP
- Analyst Count
- TERN 6
- NXP 0
- Target Price
- TERN $13.99
- NXP N/A
- AVG Volume (30 Days)
- TERN 1.1M
- NXP 70.0K
- Earning Date
- TERN 11-11-2025
- NXP 01-01-0001
- Dividend Yield
- TERN N/A
- NXP 4.04%
- EPS Growth
- TERN N/A
- NXP N/A
- EPS
- TERN N/A
- NXP 0.54
- Revenue
- TERN N/A
- NXP N/A
- Revenue This Year
- TERN N/A
- NXP N/A
- Revenue Next Year
- TERN N/A
- NXP N/A
- P/E Ratio
- TERN N/A
- NXP $26.81
- Revenue Growth
- TERN N/A
- NXP N/A
- 52 Week Low
- TERN $1.87
- NXP $12.91
- 52 Week High
- TERN $10.70
- NXP $14.89
- Technical
- Relative Strength Index (RSI)
- TERN 54.96
- NXP 75.05
- Support Level
- TERN $6.78
- NXP $13.93
- Resistance Level
- TERN $7.67
- NXP $14.55
- Average True Range (ATR)
- TERN 0.43
- NXP 0.09
- MACD
- TERN -0.06
- NXP 0.04
- Stochastic Oscillator
- TERN 39.81
- NXP 67.19
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
About NXP Nuveen Select Tax Free Income Portfolio
Nuveen Select Tax Free Income Portfolio is a closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax, consistent with preservation of capital. The fund invests a majority of its assets in municipal securities and other related investments, the income from which is exempt from regular federal income tax and federal alternative minimum tax.